Michael J. Farrell - Nov 23, 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Executive Officer
Signature
Michael J. Farrell, Chief Executive Officer
Stock symbol
RMD
Transactions as of
Nov 23, 2022
Transactions value $
-$7,458,832
Form type
4
Date filed
11/23/2022, 05:32 PM
Previous filing
Nov 18, 2022
Next filing
Dec 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Award $0 +56.1K +13.55% $0.00 470K Nov 23, 2022 Direct F1
transaction RMD ResMed Common Stock Tax liability -$7.46M -33.2K -7.07% $224.40 437K Nov 23, 2022 Direct F2
holding RMD ResMed Common Stock 4.09K Nov 23, 2022 Lisette and Michael Farrell Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on November 23, 2022, when the compensation committee certified that the performance metrics were met.
F2 Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/21/2019.